A shadow economy for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on communication apps, according to recent findings.
Experimental Drug Gaining Popularity Online
Retatrutide, which is still in research studies, is being promoted by online personalities for its supposed fat-burning properties. Followers are urged to message these accounts directly for source information, while also receiving discount codes.
Thriving Trade on Messaging Platforms
Separately, a flourishing trade exists on messaging services, where groups with thousands of members share “before and after” images, administration instructions and claims of next-day British shipping. Sellers market the substance there before directing buyers to WhatsApp for transactions.
Learning About Retatrutide
Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could help patients lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.
Healthcare Professionals Voice Concerns
Nevertheless, doctors and chemists have cautions that the distribution of what remains an unlicensed medication in the UK is a cause for concern and could result in users administering substances of uncertain source.
Several professionals stated the popularity for retatrutide could be connected to the increasing price of licensed slimming products such as Mounjaro.
Legal Position and Enforcement
Marketing retatrutide on social media or messaging apps is illegal in the UK, as it is an unlicensed drug that cannot be marketed or supplied for personal consumption under the British medical regulations.
Several content creators attempt to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still breach pharmaceutical, marketing, and customer regulations, potentially leading to penalties, prosecution or prison.
Service Reaction and Content Removal
Based on the social media company, the service has removed problematic content and prohibited related hashtags and query recommendations. The company stated it was dedicated to keeping the platform safe and investing in strengthening compliance measures.
Online Marketplace Operations
Investigations also found communities with up to nine thousand participants marketing retatrutide using Telegram's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” immediately brings up groups with thousands of members, filled with images of weight loss, positive testimonials and detailed instructions for mixing or administering at residence.
Within moments of entering one community, a vendor posted WhatsApp details, where the majority of purchases occur. The vendor provided an instruction manual and promised shipping within 48 hours. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a image of a supposed testing documentation. None asked about weight, medical conditions or past usage.
Product Details and Costs
Within these communities, posts display dark colored parcels with postal service labels, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, prepared at residence with sterile water, or ready-to-use injectors usually priced at 160 pounds for 20 milligrams. When asked how long a pen should last, sellers give conflicting responses varying between a few weeks to “depends on your body”.
Platform Moderation and Safety Actions
A spokesperson for the messaging service said it actively moderated dangerous content on its platform including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“Individuals are administering materials they can’t verify. Even if the research behind this drug is valid, these online products may not contain what they claim,” said a pharmacy expert, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to current cost increases for authorized slimming medications such as Mounjaro. “With prices rising, individuals are turning to online platforms. But fake treatments are highly dangerous. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she explained.
Her team has already seen patients harmed by self-injection from unverified sources. “We recognize the disappointment, but buying from Telegram or communication platforms is taking chances with your well-being,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Position
A representative from Eli Lilly stated the substance was in third stage clinical trials and had not been evaluated or approved by any government authority globally. “Consequently at this point no one can market [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a Lilly experimental substance not yet approved … may expose patients to possibly serious health risks”.
